These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 32778238

  • 1. miR-34a-5p suppresses the invasion and metastasis of liver cancer by targeting the transcription factor YY1 to mediate MYCT1 upregulation.
    Xu XP, Peng XQ, Yin XM, Liu Y, Shi ZY.
    Acta Histochem; 2020 Sep; 122(6):151576. PubMed ID: 32778238
    [Abstract] [Full Text] [Related]

  • 2. YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress.
    Qu SY, Sun YY, Li YH, Xu ZM, Fu WN.
    Cancer Med; 2017 Jun; 6(6):1389-1398. PubMed ID: 28485541
    [Abstract] [Full Text] [Related]

  • 3. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway.
    Zhang YM, Wu QM, Chang LY, Liu JC.
    Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. LncRNA LINC00668 promotes cell proliferation, migration, invasion ability and EMT process in hepatocellular carcinoma by targeting miR-532-5p/YY1 axis.
    Xuan W, Zhou C, You G.
    Biosci Rep; 2020 May 29; 40(5):. PubMed ID: 32249890
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. miR-34a-5p plays an inhibitory role in hepatocellular carcinoma by regulating target gene VEGFA.
    Niu X, Wei N, Peng L, Li X, Zhang X, Wang C.
    Malays J Pathol; 2022 Apr 29; 44(1):39-52. PubMed ID: 35484885
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F, Chang RM, Yu L, Lei X, Xiao S, Yang H, Yang LY.
    J Hepatol; 2015 Oct 29; 63(4):874-85. PubMed ID: 25998163
    [Abstract] [Full Text] [Related]

  • 13. YY1-C/EBPα-miR34a regulatory circuitry is involved in renal cell carcinoma progression.
    Weng W, Wang M, Xie S, Long Y, Li F, Sun F, Yu Y, Li Z.
    Oncol Rep; 2014 Apr 29; 31(4):1921-7. PubMed ID: 24481728
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. miR-632 Functions as Oncogene in Hepatocellular Carcinoma via Targeting MYCT1.
    Pu J, Wang J, Xu Z, Lu Y, Wu X, Wu Y, Shao Z, Tang Q, Wei H.
    Hum Gene Ther Clin Dev; 2019 Jun 29; 30(2):67-73. PubMed ID: 30982352
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MiR-200c-5p suppresses proliferation and metastasis of human hepatocellular carcinoma (HCC) via suppressing MAD2L1.
    Li Y, Bai W, Zhang J.
    Biomed Pharmacother; 2017 Aug 29; 92():1038-1044. PubMed ID: 28609841
    [Abstract] [Full Text] [Related]

  • 18. The Long Noncoding RNA NEAT1 Targets miR-34a-5p and Drives Nasopharyngeal Carcinoma Progression via Wnt/β-Catenin Signaling.
    Ji Y, Wang M, Li X, Cui F.
    Yonsei Med J; 2019 Apr 29; 60(4):336-345. PubMed ID: 30900419
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-34a-5p suppresses tumorigenesis and progression of glioma and potentiates Temozolomide-induced cytotoxicity for glioma cells by targeting HMGA2.
    Ma S, Fu T, Zhao S, Gao M.
    Eur J Pharmacol; 2019 Jun 05; 852():42-50. PubMed ID: 30851271
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.